TTEK Form 4: Director Gary Birkenbeuel Sells 2,390 Shares at $36
Gary Birkenbeuel, a director of Tetra Tech, Inc. (TTEK), reported a sale of common stock on 08/14/2025.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Gary Birkenbeuel, a director of Tetra Tech, Inc. (TTEK), reported a sale of common stock on 08/14/2025. The Form 4 shows 2,390 shares sold at an exact price of $36.0042 per share, leaving 37,725 shares beneficially owned after the transaction. The filing notes that a 5-for-1 forward stock split effective September 6, 2024 increased the prior balance by 32,092 shares. The Form 4 was signed on behalf of the reporting person by an attorney-in-fact on 08/15/2025. No derivative transactions or additional transactions are reported.
Insights
TL;DR Director sale of 2,390 TTEK shares at $36.0042 is a routine insider transaction with no disclosed derivatives or other material events.
The reported sale reduces the director's direct holdings to 37,725 shares. The filing explicitly records the effect of a prior 5-for-1 forward split that increased the share count. There are no other transactions or compensatory grants disclosed. From a market-impact perspective this isolated sale is small relative to typical market volumes and provides limited new information about company fundamentals.
TL;DR This Form 4 documents a standard director share disposition and contains clear disclosure about post-split share counts and signature authority.
The form identifies the reporting person as a director and the transaction code as a sale. The inclusion of a power-of-attorney signature is properly disclosed. There are no indications of plan-based trades or Rule 10b5-1 statements in the filing. Governance-wise, the filing appears compliant and routine, without signs of unusual insider activity.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | COMMON STOCK | 2,390 | $36.0042 | $86K |
Footnotes (2)
- F1. All shares sold at an exact price.
- F2. On September 6, 2024, the balance of 8,023 shares of common stock was updated pursuant to a 5 to 1 forward stock split, resulting in an additional 32,092 shares of common stock.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Gary Birkenbeuel report on the TTEK Form 4?
Does the filing disclose any option or derivative transactions for TTEK?
Who signed the Form 4 for Gary Birkenbeuel and when?
Is there any indication the sale was made under a Rule 10b5-1 plan?
AI-generated analysis. How Rhea-AI works. Not financial advice.